PatientView survey
Boehringer Ingelheim among top ten most “patient-centric” pharma companies
Vyhledat
Perceived burden of COPD is higher for younger patients
New global survey reveals perceived burden of disease is greater in younger people living with COPD
GastroGard the first imported equine drug in China
GastroGard® approved as the first imported equine drug in China. Boehringer Ingelheim officially starts equine health business in China.
New spesolimab data show significant improvement in GPP flares
New spesolimab data show significant improvement in GPP flares